Clinical Development of Cell Therapies: Setting the Stage for Academic Success-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Development of Cell Therapies: Setting the Stage for Academic Success

Published:2016-11-16 Issue:1 Volume:101 Page:35-38
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Abou-El-Enein M¹²,Volk H-D¹³,Reinke P¹²

Affiliation:

1. Berlin-Brandenburg Center for Regenerative Therapies (BCRT); Charité - Universitätsmedizin Berlin; Berlin Germany

2. Department of Nephrology and Internal Intensive Care; Charité - Universitätsmedizin Berlin; Berlin Germany

3. Institute of Medical Immunology; Charité - Universitätsmedizin Berlin; Berlin Germany

Funder

European Commission's Seventh Framework Programme

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.523/fullpdf

Reference6 articles.

1. Novel GMP-compatible protocol employing an allogeneic B cell bank for clonal expansion of allospecific natural regulatory T cells;Landwehr-Kenzel;Am. J. Transplant.,2014

2. Permanent CNI treatment for prevention of renal allograft rejection in sensitized hosts can be replaced by regulatory T cells;Siepert;Am. J. Transplant.,2012

3. Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning;Juvet;Am. J. Transplant.,2014

4. Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs;Abou-El-Enein;Cytotherapy,2013

5. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/07/WC500210825.pdf

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Problem to solution; from mammalian skin grafts to renal allograft rejection: a tale of 66 years of evolution of our understanding;Journal of the Pakistan Medical Association;2023-05-15

2. Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches;Drug Delivery and Translational Research;2023-02-10

3. Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products ex vivo and in vivo;Frontiers in Cell and Developmental Biology;2021-12-03

4. RESTORE Survey on the Public Perception of Advanced Therapies and ATMPs in Europe—Why the European Union Should Invest More!;Frontiers in Medicine;2021-10-26

5. Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy;Blood Cancer Discovery;2021-08-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3